Jan 18 | News
Takeda Pharmaceutical Company Limited announced today strategic measures to better align its global workforce and consolidate site operations in order to integrate legacy Nycomed operations, strengthen its presence in more than 70 countries, adapt to changing market conditions and maintain a focus on growth.
|
Sep 30 2011 | News
Takeda Pharmaceutical Company Limited announced it has completed its acquisition of Nycomed A/S for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary
|
Jan 12 2011 | News
Eurand N.V. has reached
an agreement with Nycomed to sell and distribute Zenpep in Russia and the Commonwealth of Independent
States as well as Georgia
and Mongolia.
Deal terms were not disclosed.
|
Aug 6 2010 | News
Nycomed US Inc. has announced the appointment of Jeff Wasserstein as its new Sr. Vice President, Business Development and Strategy
|
Jul 19 2010 | News
Nycomed US Inc. today announced the appointment of Steve Andrzejewski as the new Chief Executive Officer. He assumes immediate responsibility for Nycomed US Inc., including manufacturing in Melville and Hicksville, New York, distribution and commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and Savage Laboratories.
|
Jul 19 2010 | News
Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc.
|
Aug 10 2009 | News
NEW YORK (AP) —Forest Laboratories Inc. said Monday it signed a deal to sell Nycomed's developing chronic bronchitis drug Daxas in the U.S. Under the deal, Forest Laboratories will pay Nycomed $100 million up front, plus future milestone payments. Nycomed will also receive royalties on U.S.
|
Mar 24 2009 | News
NEW YORK (AP) — Swiss drug company Nycomed could be in the market sell itself for as much as 10 billion euro, or $13.57 billion, according to a media report Monday.
|
Aug 8 2008 | News
BioSante Pharmaceuticals, Inc. has reacquired Elestrin (estradiol gel) from Nycomed US who in February 2008 acquired Bradley Pharmaceuticals, Inc., BioSante’s previous licensee of Elestrin. BioSante will immediately assume all manufacturing, distribution and marketing responsibilities for Elestrin.
|
May 14 2008 | News
Medimetriks Pharmaceuticals, Inc. recently announced that it has commenced operations. The
|